Cargando…
Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile
BACKGROUND: Omalizumab is the first biological therapy used to treat moderate-to-severe asthma and certainly the one with the highest number of publications. METHODS: A systematic review and meta-analysis were performed to examine two critical outcomes of omalizumab therapy, asthma exacerbation rate...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020639/ https://www.ncbi.nlm.nih.gov/pubmed/36937051 http://dx.doi.org/10.3389/fped.2022.1033511 |